NCT07069374Completed
Wellness, Intervention Strategies and HIV Care
Source: ClinicalTrials.gov · Last updated 15 Sept 2026
Brief summary (registry, in English)
This is a pilot trial designed to assess the feasibility and acceptability of an intervention aimed at improving adherence to antiretroviral therapy (ART), viral suppression, and engagement in HIV care. The intervention will address behavioral coping strategies, HIV care engagement behaviors, and substance use management.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 7 Jul 2025
- Start date
- 1 Sept 2025
- Primary completion date
- 21 Jul 2026
- Lead sponsor
- University of California, San Francisco
- Diseases
- HIV
- NCT number
- NCT07069374
What you commit to
- Study type: Interventional
- Participants enrolled: 33
- From 1 Sept 2025 to the primary completion date, 21 Jul 2026
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Evidence of severe cognitive impairment or active psychosis that may impede ability to provide fully informed consent, determined by the research assistants and clinical supervisor(s)
- The research staff are trained on guidelines for identifying participants who exhibit signs of inability to meaningfully participate or provide consent due to mental illness or impairment
Who the study is looking for
- Participants must:
- Be at least 18 years of age
- Self-report biological characteristics consistent with the population under study
- Be HIV-positive
- Report use of at least one of the following substances in the last 90 days:
- Cannabis
- Methamphetamine
- Cocaine/crack
- Cocaine
- Heroin
- Non-prescribed opioids (e.g., fentanyl, morphine)
- Ecstasy
- Phencyclidine (PCP)
- Psychedelics (e.g., Lysergic acid diethylamide, mescaline, ketamine)
- Poppers (alkyl nitrites)
- Non-prescribed benzodiazepines (e.g., Valium, Xanax, Klonopin, Librium)
- Barbiturates
- Be English-speaking
- Be able and willing to provide informed consent
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Oakland MWCCS Site Office Coordinator of this site? Confirm its status | Oakland | United States | Unknown status |
| SF MWCCS Site Office Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.